ロード中...
Transcatheter arterial chemoembolization plus sorafenib versus transcatheter arterial chemoembolization alone to treat advanced hepatocellular carcinoma: a meta-analysis
BACKGROUND: Many studies have combined sorafenib with transcatheter arterial chemoembolization (TACE) to treat patients with advanced hepatocellular carcinoma (HCC), but the results are disputable. Thus, we conducted this meta-analysis to assess the efficacy and safety of the combination treatment i...
保存先:
出版年: | BMC Cancer |
---|---|
主要な著者: | , , , , , , , , , , , |
フォーマット: | Artigo |
言語: | Inglês |
出版事項: |
BioMed Central
2017
|
主題: | |
オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5674853/ https://ncbi.nlm.nih.gov/pubmed/29110700 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-017-3707-5 |
タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|